Seed · Biotech · Oxford, United Kingdom · Founded 2021 · 3–7 employees
Evolvere BioSciences is developing next-generation antibiotics using AI and co-evolutionary protein datasets to outpace bacterial evolution and prevent drug resistance. The Oxford-based startup, founded by University of Oxford biochemists and evolutionary biologists, uses computational models to create precision antibiotics that target pathogenic bacteria while preserving beneficial microbes and human cells. The company was accepted into Y Combinator's S24 batch and has raised $500K in funding. Their approach addresses the global antibiotic resistance crisis by designing 'future-proof' antibiotics that can stay ahead of bacterial mutations.
No open roles listed right now.